Chromatin immunoprecipitation assays showed that the binding of NF-κB1 to BCL2, SNAIL, and MMP9 promoters was significantly reduced in p65/S536D-overexpressing HCC cells (Figure 4G). This evidence concerns the gene BCL2 and hepatocellular carcinoma.